「by」の検索結果
79件：16～20件目を表示
-
发表论文 | 研究与开发 | 千寿制药株式会社
apy. 2024 Oct;13(10):2629-2644. Identification of meibomian gland testosterone metabolites produced by tissue-intrinsic intracrine deactivation activity Khanh Tien Nguyen Pham 1, Takahito Miyake 1, To...
http://www.senju.co.jp/chinese/rd/thesis/ -
that it has received approval for the marketing of “Mytear Lumify” (OTC drug requiring instruction by pharmacist, hereinafter this "Product") from Ministry of Health, Labour and Welfare. Th...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
that it has received approval for the marketing of “Mytear Lumify” (OTC drug requiring instruction by pharmacist, hereinafter this "Product") from Ministry of Health, Labour and Welfare. Th...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
ical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of RET-700 in Japan, effective immediately (medical device a...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf -
aceutical Co., Ltd. Launch and Distribution of “MIEr for NAVIS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for NAVIS” in Japan. MIEr for NAVIS can...
https://www.senju.co.jp/system/files/content_news/2024-04/ENG_20240423_0.pdf